Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Journal of Chromatography
|
May 18, 1990
Determination of the oximes 2-hydroxyiminomethyl-3-methyl-1-[2-(3-methyl- 3-nitrobutyloxymethyl)]imidazolium chloride and 1-[1-(3-butynyloxymethyl)]-2-hydroxyiminomethyl-3-methylimida zolium chloride in plasma by high-performance liquid chromatography
S Ferraris, D W Korte
Clinical Chemistry and Laboratory Medicine
|
August 28, 2001
Comparability of serum and plasma concentrations of haemostasis activation markers
W Korte, W F Riesen
Therapeutische Umschau. Revue Therapeutique
|
March 17, 2004
[Differential diagnosis of absolute lymphocytosis]
A Gähler, S Cogliatti, W Korte
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1978
The effect of the combination of quinidine and propranolol upon atrial and ventricular automatically in dogs
D W Korte, C B Nash
Swiss Medical Weekly
|
March 5, 2002
Repetitive intraoperative use of recombinant hirudin (Lepirudin) in peripheral vascular surgery with HITT
F Goti, W Korte, D Sege
The Journal of Pharmacology and Experimental Therapeutics
|
May 11, 1976
Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart
D W Korte, C B Nash
Schweizerische Medizinische Wochenschrift
|
March 4, 1995
[Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?]
W Korte, C Corbetta, L Schmid
Journal of Pain and Symptom Management
|
March 1, 1996
Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients
W Korte, N de Stoutz, R Morant
Therapeutische Umschau. Revue Therapeutique
|
February 3, 2006
[Paroxysmal nocturnal hemoglobinuria--consequences of a missing anchor]
W Korte, I A F M Heijnen
American Journal of Clinical Pathology
|
January 13, 2000
Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism
W Korte, S Clarke, J B Lefkowitz
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Journal of Chromatography
|
May 18, 1990
Determination of the oximes 2-hydroxyiminomethyl-3-methyl-1-[2-(3-methyl- 3-nitrobutyloxymethyl)]imidazolium chloride and 1-[1-(3-butynyloxymethyl)]-2-hydroxyiminomethyl-3-methylimida zolium chloride in plasma by high-performance liquid chromatography
S Ferraris, D W Korte
Clinical Chemistry and Laboratory Medicine
|
August 28, 2001
Comparability of serum and plasma concentrations of haemostasis activation markers
W Korte, W F Riesen
Therapeutische Umschau. Revue Therapeutique
|
March 17, 2004
[Differential diagnosis of absolute lymphocytosis]
A Gähler, S Cogliatti, W Korte
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1978
The effect of the combination of quinidine and propranolol upon atrial and ventricular automatically in dogs
D W Korte, C B Nash
Swiss Medical Weekly
|
March 5, 2002
Repetitive intraoperative use of recombinant hirudin (Lepirudin) in peripheral vascular surgery with HITT
F Goti, W Korte, D Sege
The Journal of Pharmacology and Experimental Therapeutics
|
May 11, 1976
Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart
D W Korte, C B Nash
Schweizerische Medizinische Wochenschrift
|
March 4, 1995
[Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?]
W Korte, C Corbetta, L Schmid
Journal of Pain and Symptom Management
|
March 1, 1996
Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients
W Korte, N de Stoutz, R Morant
Therapeutische Umschau. Revue Therapeutique
|
February 3, 2006
[Paroxysmal nocturnal hemoglobinuria--consequences of a missing anchor]
W Korte, I A F M Heijnen
American Journal of Clinical Pathology
|
January 13, 2000
Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism
W Korte, S Clarke, J B Lefkowitz
Page
of 8